Shenzhen Genocury Biotech Co., Ltd.

This early study tests a new treatment called CD19/BCMA CAR-T for 20 people with severe autoimmune diseases like lupus or Sjögren's syndrome that haven't responded to standard therapies. The main goal is to check if the treatment is safe and tolerable, not yet to prove it works. …